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Background: Hyaluronate is one of the major components of extracellular matrix from vertebrates whose breakdown
is catalyzed by the enzyme hyaluronidase. These enzymes are widely described in snake venoms, in which they
facilitate the spreading of the main toxins in the victim’s body during the envenoming. Snake venoms also present
some variants (hyaluronidases-like substances) that are probably originated by alternative splicing, even though their
relevance in envenomation is still under investigation. Hyaluronidases-like proteins have not yet been purified from any
snake venom, but the cDNA that encodes these toxins was already identified in snake venom glands by transcriptomic
analysis. Herein, we report the cloning and in silico analysis of the first hyaluronidase-like proteins from a Brazilian snake
venom.
Methods: The cDNA sequence of hyaluronidase was cloned from the transcriptome of Bothrops pauloensis venom
glands. This sequence was submitted to multiple alignment with other related sequences by ClustalW. A phylogenetic
analysis was performed using MEGA 4 software by the neighbor joining (NJ) method.
Results: The cDNA from Bothrops pauloensis venom gland that corresponds to hyaluronidase comprises 1175 bp and
codifies a protein containing 194 amino acid residues. The sequence, denominated BpHyase, was identified as
hyaluronidase-like since it shows high sequence identities (above 83%) with other described snake venom
hyaluronidase-like sequences. Hyaluronidases-like proteins are thought to be products of alternative splicing
implicated in deletions of central amino acids, including the catalytic residues. Structure-based sequence alignment
of BpHyase to human hyaluronidase hHyal-1 demonstrates a loss of some key secondary structures. The phylogenetic
analysis indicates an independent evolution of BpHyal when compared to other hyaluronidases. However, these toxins
might share a common ancestor, thus suggesting a broad hyaluronidase-like distribution among venomous snakes.
Conclusions: This work is the first report of a cDNA sequence of hyaluronidase from Brazilian snake venoms. Moreover,
the in silico analysis of its deduced amino acid sequence opens new perspectives about the biological function of
hyaluronidases-like proteins and may direct further studies comprising their isolation and/or recombinant production,
as well as their structural and functional characterization.
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“Hyaluronidase” is a term introduced by Meyer [1] to
denote any enzyme that degrades hyaluronate. These en-
zymes are present in human testis, spleen, skin, eye,
liver, kidney, uterus, placenta, tear, blood and sperm [2].
Hyaluronidases from many animal classes usually share
common structural features, conserving all the critically
important sites for enzyme activity [3]. Hyaluronidases
were identified at first in bovine testis and in bacteria and
were subsequently described as “spreading factors” [4,5].
Hyaluronidases are often found in a diversity of
venoms, such as those from snakes, lizards and arthro-
pods (scorpions, spiders, wasps and bees), in which they
act as an immunogen. In snake venoms, this enzyme po-
tentiates the toxicity and contributes to local damage at
the bite site by affecting the extracellular matrix integrity
due to hyaluronate degradation [6-8].
There are also some hyaluronidase variants, known as
hyaluronidase-like proteins, which are products of alter-
native splicing [9]. These truncated forms of hyaluroni-
dases have been recently identified in snake and bee
venoms and in human serum as well [3,10,11]. Ever since,
some questions have been raised about their physiological
role. A hyaluronidase-like isoform from Vespula vulgaris
venom was hypothesized to act as a lectin by binding to
hyaluronate and/or other related substances without de-
grading them [11].
The isolation and biological characterization of hyal-
uronidases from snake venoms, including Bothrops
genus, are usually difficult to achieve due to their in-
stability and fast degradation, and because of their rela-
tively low concentration in these biological samples.
However, the purification of hyaluronidases from Naja
naja, Agkistrodon contortrix contortrix, Cerastes cerastes
and Crotalus durissus terrificus venoms has already been
reported [12-15]. In the present work, we describe the
molecular cloning and in silico analysis of a cDNA se-
quence that encodes a hyaluronidase-like protein from
the Bothrops pauloensis venom gland. The sequence was
compared to other known hyaluronidase-like sequences
in order to screen conserved structural features, which
may generate perspectives regarding its potential physio-
logical functions and contributions to the envenoming.
Methods
Isolation of cDNA hyaluronidase from Bothrops pauloensis
venom gland
A venom gland from a B. pauloensis adult snake was dis-
sected three days after venom extraction, when tran-
scription is most stimulated [16]. A cDNA library from
Bothrops pauloensis venom gland, formerly referred to
as Bothropoides pauloensis, was previously constructed
by Rodrigues et al. [17]. Briefly, the pair of venom glands
was homogenized by liquid nitrogen and the total RNAwas extracted by the Trizol method (Invitrogen, UK). The
mRNA was purified from total RNA by using PolyATract®
mRNA Isolation kit (Promega, USA) and the cDNA
library was obtained by CloneMiner cDNA Library Con-
struction kit (Invitrogen, UK) with 3 μg of purified mRNA.
First and second cDNA strands were synthesized as de-
scribed by the manufacturer protocols whereas size frac-
tioning of cDNA was carried out in a 1 mL column
previously packed with Sephacryl S-500 resin. The cDNA
was precipitated with ethanol and then resuspended in
50 mL of milli-Q water and submitted to Polymerase
Chain Reaction (PCR). The PCR products were purified
and sequenced using DYEnamic ET Terminator Cycle
Sequencing kit (GE Healthcare, UK) on a MEGA-BACE
1000 automated DNA sequencer (GE Healthcare, UK).
After the cDNA sequencing, specific primers were de-
signed in order to certify that the full open reading frame
(ORF) was obtained. The specific primers were Hyase in-
ternal forward (5′-TTGGTGAAACAGCGGCCATG-3′)
and Hyase internal reverse (5′-CTTTTCATCCAGCA
CAATAC-3′). After amplification, the PCR products were
analyzed by electrophoresis on 1% agarose gel. The bands
containing the PCR products were purified from gel
using the Wizard SV Gel and PCR clean up system kit
(Promega, Brazil), according to the manufacturer’s specifi-
cations. The Ins T/A clone PCR Product kit (Fermentas,
Lithuania) was used for rapid cloning of PCR products in
pTZ57R/T plasmids. Bacteria colonies were selected on a
medium containing ampicillin, IPTG and X-Gal. The
recombinant colonies were analyzed by PCR and gel
electrophoresis. PCR products were purified and sub-
mitted to sequencing using DYEnamic ET Terminator
Cycle Sequencing Kit (GE Healthcare, UK) on a MEGA-
BACE 1000 automated DNA sequencer (GE Healthcare,
UK). The software Base Caller Cimarron 3.12 was used to
analyze the electropherograms and generate sequences,
which were then aligned in the software Bioedit version
7.0.5.3.
In silico analysis of cDNA sequences
Hyaluronidase sequences were searched against the NCBI
database (http://www.ncbi.nlm.nih.gov/). BLASTp 2.2.19
was used for scoring the sequence alignments and the max-
imum e-value obtained was 2e−100 [18]. The predicted se-
quence of hyaluronidase from Bothrops pauloensis venom
and other full-length hyaluronidases and hyaluronidase-like
sequences from the database were aligned by ClustalW
(available in http://www.ebi.ac.uk/Tools/clustalw2/index.
html). The putative glycosylation sites were identified by
the glycosylation prediction software NetNGlyc (http://
www.cbs.dtu.dk/services/NetNGlyc/). Predicted signal pep-
tide cleavage site was determined by the SignalP algorithm
[19]. The theoretical isoelectric point and molecular mass
were computed using the tool ProtParam [20].
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Sequences were aligned by ClustalW algorithm and the
phylogenetic analysis was performed using the software
MEGA 4 by the neighbor joining (NJ) method [21]. The
evolutionary distances were computed by the JTT matrix-
based method. The reliability of NJ trees was evaluated by
analyzing 1000 bootstrap replicates. Human hyaluronidase
(NP009296.1) was employed as an out-group.
Results and discussion
Since snakes need to kill their prey quickly and efficiently,
a systemic delivery of the main venom toxins is required
in order to potentiate the lethal effects. Thus, these toxins
enter into the circulatory system of the victim with the aid
of toxins that degrade the extracellular matrix (ECM)
(metalloproteinases, myotoxic phospholipases A2 and hy-
aluronidases) [10]. Hyaluronidases have been identified in
some snake venoms, such as those from Agkistrodon acu-
tus, Naja naja,Vipera russelli siamensis, Trimeresurus fla-
voviridis, Trimeresurus popeorum, Trimeresurus macrops,
Trimeresurus albolabris, Agkistrodon contortrix contortrix
and Crotalus durissus terrificus [6,15,22-24].
In this study, we present the amino acid sequence of a
hyaluronidase-like (BpHyase) protein deduced from a
cDNA obtained from B. pauloensis venom gland tran-
scriptome [17]. Interestingly, the identification of a sin-
gle truncated hyaluronidase-encoding EST was achieved
in an attempt to clone true hyaluronidase, which may re-
flect its low representation in the venom when com-
pared to other toxin classes. On the other hand, most
snake venom-gland transcriptomes reveal the presence
of transcripts corresponding to hyaluronidase [10,25].
The cDNA sequence of hyaluronidase from B. pauloen-
sis gland, denominated BpHyase, is composed of 1175 bp
and codifies 194 amino acid residues for the mature pro-
tein, including eight cysteine residues (Figure 1). The full-
length sequence of BpHyase comprises an ORF of 582 bp,
flanked by a 5′ UTR of 100 bp and a 3′ UTR of 493 bp.
The initiating methionine of BpHyase is followed by a pre-
dicted signal peptidase I (SPase I) cleavage site at FNG20-
VH, which is consistent with the secreted nature of toxins.
This prepeptide is believed to initiate the transport of
preBpHyase into the endoplasmatic reticulum for gly-
cosylation and is characterized by an N-terminal basic
region (Met1-Lys7), a hydrophobic region (Cys8-Phe14)
and a polar C-terminal (Leu15-Gly20) [26]. The pres-
ence of a prepeptide followed by a start codon indicates
that BpHyase is probably translated into protein. More-
over, this prepeptide probably releases a mature protein
that, after cleavage, possesses 174 amino acids with a the-
oretical pI of 9.60 and molecular mass of 19,892.3 Da.
Therefore, this prepeptide may act as a signal sequence
that directs the protein to the secretory pathway of venom
gland cells [25].The presence of N-linked glycans is supposed to be
necessary for the stabilization of intramolecular folding
and the consequent retention of enzymatic activity.
Furthermore, changes in glycosylation are likely respon-
sible for the diversity of biological functions exhibited
by protein isoforms [27]. In relation to BpHyase, several
asparagine residues identified in its sequence could po-
tentially constitute glycosylation sites, thus influencing
some physical and chemical parameters of the mol-
ecule. The glycosylation prediction algorithm (NetN-
Glyc) indicated the following glycosylation sites for
BpHyase: N101, V102, T103 and N146, A147 and T148
(Figure 2). The glycosylation consensus triad is NXS or
T, where X represents any amino acid, except proline
[28,29]. However, further structural analyses are of
great importance to reveal the residues truly involved
in glycosylation.
Three cDNA variants of truncated hyaluronidase from
Echis pyramidum leakeyi, Echis carinatus sochureki and
Bitis arietans venom glands were already identified: Hy-L-
1000 that encodes the consensus amino- and carboxy-
termini with a central deletion of 256 residues, Hy-L-750
that lacks the consensus amino-terminus and Hy-L-500
that lacks the amino-terminus and encodes a shorter
carboxy-terminal segment [10]. Hy-L-1000 is probably
translated into a protein without enzymatic activity, while
Hy-L-750 and Hy-L-500 represent non-translated tran-
scripts due the absence of an essential translation initiat-
ing motif. The inferred protein-coding sequence of
BpHyase was classified into the Glycol-Hydro-56 super-
family by protein BLAST analysis, and the highest identity
(88%) was presented by truncated hyaluronidase from
Echis carinatus sochureki venom (GenBank: ABI33950)
(Figure 2). In order to confirm its identity, BpHyase
was aligned by ClustalW algorithm against other re-
ported hyaluronidase-like sequences from snake venoms,
in which the highest sequence identities (above 86%) were
observed for Hy-L-1000 truncated hyaluronidases, reveal-
ing that BpHyase presents the same residue deletion pat-
tern as these molecules.
It would be tempting to speculate that partial hyaluroni-
dases or hyaluronidases-like proteins represent vestigial
enzymes with no activity, since some authors affirmed
they lack catalytic residues because of deletions of central
residues during their evolutionary history [10,30,31]. The
predicted BpHyase amino acid sequence was aligned with
other full-length and truncated hyaluronidases from snake
venoms, as well as human hyaluronidase (hHyal-1), in
order to investigate its deletion pattern (Figure 3). The
multiple alignment revealed a substantial deletion of 255
amino acids, starting at residue 52, resulting in the loss of
two cysteines, the catalytic (Glu135) and positional resi-
dues (Asp133, Tyr206, Tyr253) from full-length viper hyal-
uronidases. Structural data, site-directed mutagenesis and
TTTCGACTGCCCTTGTCTtGTGTCTGGACCCTACCTGGTGGATTGGACTTGGAACCCTG 59
GACCTTGCCCTGAACTAACAGCACCAGAAAATCTGCATATTATGTATCACCTATGGATC 118
M  Y  H  L  W  I 6
AAATGCCTGGCAGCTTGGATATTTCTGAAGAGATTTAATGGAGTTCATGTTATGCATGC 177
K C  L  A  A  W  I  F L  K  R  F  N  G V  H  V  M  H  A 26
CAAAGCTCCAATGTATCCTAATGAGCCTTTCCTTGTGTTCTGGAATGCACCTACTACCC 236
K A  P  M  Y  P  N  E  P  F  L  V  F  W  N  A  P  T  T 45
AATGTCGGCTGCGCTATAAGGAAGACTTGGTGACTACAGTTGGTGAAACAGCGGCCATG 295
Q  C  R  L  R  Y  K  E  D  L  V  T  T  V  G  E  T  A  A  M 65
GGGGCAGCAGGAATTGTCTTTTGGGGAAGCATGCAATATGCCAGTACTGTTGAAAGCTG 354
G  A  A  G  I  V  F  W  G  S  M  Q  Y  A  S  T  V  E  S  C 85
TGGAAAAGTGAAAGACTATATGAATGGTCCATTGGGACGTTATATCGTTAATGTAACTA 413
G  K  V  K  D  Y  M  N  G  P  L  G  R  Y  I  V  N  V  T 104 
CTGCAGCCAAGATTTGCAGCCGTTTCCTTTGCAAGAGACATGGAAGATGTGTTCGGAAA 472
T  A  A  K  I  C  S  R  F  L  C  K  R  H  G  R  C  V  R  K 124
CATAGTGATTCAAATGCCTTTCTACACTTGTTTCCTGATAGTTTCAGGATCATGGTGCA 531
H S  D  S  N  A  F  L  H  L  F  P  D  S  F  R  I  M  V  H 144
TGGCAATGCAACAGAAAAAAAAGTGATTGTAAAAGGAAAATTGGAGTTGAAGAATTTGA 590
G  N  A  T  E  K  K  V  I  V  K  G  K  L  E  L  K  N  L 163
TTTTCTTAAGAAATAACTTTATGTGCCATTGTTACCAAGGTTGGAAAGGACTATATTGT 649
I  F  L  R  N  N  F  M  C  H  C  Y  Q  G  W  K  G  L  Y  C 183
GAAAAGCATTCTATAAAAGAGATAAGGAAAATATAAGGAAATTAAATGCATTGAAGAGT 708









Figure 1 Full-length nucleotide and deduced amino acid sequence of BpHyase. The underlined amino acids indicate the inferred sequence
of signal peptide which is characterized by an N-terminal basic region, marked in pink, a hydrophobic region (green) and a polar C-terminal (light blue)
The nucleotide and amino acid sequences reported herein are available in GenBank with accession numbers GR955246 and FJ654998.1, respectively.
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some important residues for human Hyal-1 catalysis [32].
An essential direct role in chemical catalysis was sug-
gested for Glu131 and a supporting role for Asp129,
which was also observed by Arming et al. [33]. In these
cases, the acidic character of the residues is critical for
enzymatic activity while Glu131 acts as a proton donor
to the hydroxyl group in glycosidic cleavage. These acid
residues are also conserved into hyaluronidases from
Trichoderma reesei (Glu212 and Glu217), Bacillus agar-
adherans (Glu139 and Glu228), Echis ocellatus venom
(Asp133 and Glu 135), as well as in those from bovine
testis PH20 (Asp147 and Glu 149) and Apis mellifera
venom (Asp111 and Glu113) [34-37,10]. Moreover,Tyr202 and Tyr247 are also essential residues for cata-
lytic activity, since Tyr202 probably binds the substrate
and Tyr247 is suggested as coordinating and stabilizing
the oxidation during transition state formation [32].
Figure 3 also indicates that BpHyase encodes a protein
containing the consensus amino and carboxi-termini, as
well as Hy-L-1000 truncated hyaluronidase variants from
E. c. sochureki and Bitis arietans venoms. hHyal-1 hu-
man hyaluronidase showed a cross-generic sequence
conservation of 38% when compared to BpHyase, repre-
senting the most similar hyaluronidase that had its
structure solved. The alignment of hHyal-1 to BpHyase
allowed the mapping of the secondary structures lost by
deletions and demonstrated the lack of regions that are
BpHyase      MYHLWIKCLA AWIFLKRFNG VHVMHAKAPM YPNEPFLVFW NAPTTQCRLR 
HyL1000_Ec   MYHIWIKFLA AWIFLKRFNG VHVMQAKAPM YRNEPFLVFW NAPTTQCRLR  
HyL1000_Ec   MYHLWIKCLA AWIFLKRCNG VHAMPAKAPM YPNEPFIVLW NAPTTQCPLR  
HyL1000_Ba   MYHLWIKCLA AWIFLKRCNG VHAMPAKAPM YPNEPFIVLW NAPTTQCPLR  
HyL750_Ba    ---------- ---------- ---------- ---------- ----------
HyL500_Ba    ---------- ---------- ---------- ---------- ----------  
HyL500_Epl   ---------- ---------- ---------- ---------- ----------  
HyL500_Epl   ---------- ---------- ---------- ---------- ----------  
Clustal Co
BpHyase      YKEDLVTTVG ETAAMGAAGI VFWGSMQYAS TVESCGKVKD YMNGPLGRYI 
HyL1000_Ec   YKEDLVTTVG ETAAMGAAGI VFWGSVQYAS TVDSCQKVKK YMNGPLGRYI  
HyL1000_Ec   YKEDLVTTVG ETAAMGAAGI VFWGSMQYAS TVDSCQKVKT YMNGPLGRYI  
HyL1000_Ba   YKEDLVTTVG ETAAMGAAGI VFWGSMQYAS TVDSCQKVKT YMNGPLGRYI  
HyL750_Ba    --EDLVTTVG ETAAMGAAGI VFWGSMQYAS TVDSCQKVKT YMNGPLGRYI  
HyL500_Ba    ---------- ---------- ---------- --DSCQKVKT YMNGPLGRYI  
HyL500_Epl   ---------- ---------- ---------- --DSCQKVKT YMNGPLGRYI  
HyL500_Epl   ---------- ---------- ---------- --DSCQKVKT YMNGPLGRYI  
Clustal Co                                      :** ***  **********  
BpHyase      VNVTTAAKIC SRFLCKRHGR CVRKHSDSNA FLHLFPDSFR IMVHGNATEK  
HyL1000_Ec   VNVTTAAKIC SRVLCRKNGR CVRKHSDSNA FLHLFPESFR IMVYANATEK  
HyL1000_Ec   VNVTTAAKIC SHALCRKNGR CVRKHSDSNA FLHLFPESFR IMVHANATEK 
HyL1000_Ba   VNVTTAAKIC SHALCRKNGR CVRKHSDSNA FLHLFPESFR IMVHANATEK  
HyL750_Ba    VNVTTAAKIC SHALCRKNGR CVRKHSDSNA FLHLFPESFR IMVHANATEK 
HyL500_Ba    VNVTTAAKIC SHALCRKNGR CVRKHSDSNA FLHLFPESFR IMVHANATEK 
HyL500_Epl   VNVTTAAKIC SHALCRKNGR CVRKHSDSNA FLHLFPESFR IMVHANATEK  
HyL500_Epl   VNVTTAAKIC SHALCRKNGR CVRKHSDSNA FLHLFPESFK IMVHANATEK  
Clustal Co   ********** *: **:::** ********** ******:**: ***:.*****  
10  20 30 40  50
60  70 80 90 100
 110 120 130  140 150
Identity (%)
 160 170 180  190 
BpHyase      KVIVKGKLEL KNLIFLRNNF MCHCYQGWKG LYCEKHSIKE IRKI   100   
HyL1000_Ec   KVIVKGKLEL ENLIYLRENF MCQCYQGWKG LYCEEYSIKD IRKI    88 
HyL1000_Ec   KAIVKGKLEL KDLIYLRKNF MCQCYQGWKG LYCEEYSIKD IRKI    87 
HyL1000_Ba   KAIVKGKLEL KDLIYLRKNF MCQCYQGWKG LYCEEYSIKD IRKI    87 
HyL750_Ba    KAIVKGKLEL KDLIYLRKNF MCQCYQGWKG LYCEEYSIKD IRKI    87 
HyL500_Ba    KAIVKGKLEL KDLIYLRKNF MCQCYQGWKG LYCEEYSIKD IRKI    83 
HyL500_Epl   KAIVKGKLEL KDLIYLRKNF MCQCYQGWKG LYCEEYSIKD IRKI    83 
HyL500_Epl   KAIVKGKLEL KDLIYLRKNF MCQCYQGWKG LYCEEYSIKD IRKI    83 
Clustal Co   *.******** ::**:**:** **:******* ****::***: ****
Figure 2 BpHyase was aligned with truncated hyaluronidases from Echis carinatus sochureki (HyL1000_Ec; Genbank: ABI33950.1 and
ABI33949.1), Echis pyramidum leakeyi (HyL500_Epl; Genbank: ABI33949.1 and ABI33942.1.), and Bitis arietans (HyL1000_Ba, HyL750_Ba
and Hy-L-500; Genbank: ABI33947.1, ABI33946.1 and ABI33948.1) snake venoms. The putative points of glycosylation are marked in the boxes.
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and α-helices 2 to 6. The crystal structures of bee venom
(bvHyal) and human (hHyal-1) hyaluronidases reveal aclassical (β/α)8 TIM barrel fold, which is common to
many hydrolases [36,38,39]. In bvHyal, the barrel is
formed by only seven strands (β1- β7), in contrast to
Figure 3 Structure-based sequence alignment of mature truncated and complete hyaluronidases. Full-length hyaluronidases from Echis
pyramidum leakeyi (E_pyramidum; Genbank: ABI33941.1), Hy-L-1000 truncated hyaluronidase from Echis carinatus sochureki (E_carinatus; Genbank:
ABI33950.1), full-length hyaluronidase from Bitis arietans (B_arietans; Genbank: ABI33945.1), Hy-L-1000 truncated hyaluronidase from Bitis arietans
(B_arietans; Genbank: ABI33947.1) and human hyaluronidase (Human_hyal; Genbank: 2PE4). Key catalytic residue is shown in red and positional
residues appear in blue. Cysteine residues are marked in black. Secondary structures were based on the human hyaluronidase crystal structure [38].
Secondary structure elements for human hyaluronidase are shown below the sequences: pink arrows represent β-strands, blue cylinders α-helices, and
red cylinders 310 helices.
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The alignment of BpHyase and other hyaluronidases and
hyaluronidases-like prteins from snake venoms with
hHyal-1 demonstrates that they lack the residues
responsible for forming the β-strands 2 to 7 (Figure 3).
This fact indicates that BpHyase and other snake venom
hyaluronidases-like proteins have a different folding
pattern than that described for hHyal-1 and bvHyal,
although this does not necessarily imply a loss of
biological activity during envenoming.
Alternative splicing is a molecular mechanism by which
different combinations of exons can be alternatively linked
in order to produce different mRNA isoforms. In the
globular enzymatic proteins, such as hyaluronidase, a nega-
tive selection pressure operates against gene duplication
and diversification, since their correct folding is generally
more sensitive to mutations [40]. Therefore, alternative
splicing is the most important source of functional diver-
sity for globular proteins in eukaryotes [41,42]. Alternative
splicing variants of hyaluronidases were previously de-
scribed in hHyal-1 and hHyal-3 from human prostate
cancer cell lines and Vespula vulgaris venom [11,43].
Moreover, researchers hypothesized that spliced vari-
ants would have their function silenced and demon-
strated that some hyaluronidase splicing variants from
bladder tumor tissues would form a complex with true
hyaluronidases, displaying the spreading activity and,
consequently, regulating the functional aspects of these
true hyaluronidases by alternative mRNA splicing
[44,45]. Therefore, spliced variants of hyaluronidases
would provide a valuable tool for modeling a metastasisFigure 4 Evolutionary relationships of snake venom hyaluronidases in
was employed as the out-group.inhibitor. Nevertheless, the impact of alternative spli-
cing needs to be further investigated in hyaluronidases
from human and venoms, in order to screen a biotech-
nological application for these recently discovered en-
zymes. In the present work, we suggest that BpHyase
would also operate in association with a true hyaluroni-
dase from Bothrops pauloensis venom in order to
potentiate its activity as a “spreading factor” during the
envenoming.
In addition, it was supposed that hHyal-1 splice variants
may play regulatory roles by binding to partner proteins
via interaction with the carboxi-terminal HyalEGF-like
domain, resulting in modulation of its enzymatic activity
[38]. The EGF domain is present in many extracellular
proteins and is involved in cell adhesion and cell-cell
communication [46,47]. In mammalian hyaluronidases,
the HyalEGF-like domain is characterized by an EGF
disulfide bond signature sequence. The three disulfide
bonds of the HyalEGF-like domain are possibly respon-
sible for the maintenance of its fold even when the
catalytic domain unfolds [38]. Mapping deletions on
the BpHyase structure demonstrates that in BpHyal-1
the segment correspondent to the HyalEGF-like do-
main remains intact (Figure 3), which may confer regu-
latory roles on these hyaluronidase-like molecules. This
result is in agreement with our hypothesis that BpHyase
contributes to the spreading of the main toxins into the
envenomed body of the victim. On the other hand,
these findings have not previously been reported for
snake venoms. In this conception, further studies con-
cerning the isolation and/or heterologous expression offerred using the neighbor-joining method. Human hyaluronidase
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testifying their biological role during envenoming.
The phylogenetic analysis of hyaluronidase-like se-
quence and true hyaluronidases from the Viperidae family
(Figure 4) showed that these molecules form a monophy-
letic group, indicating a recent divergence among them.
The branches amongst BpHyase and other hyaluronidases
may be due to point mutations and/or gene duplication,
which would result in new amino acid sequences. This ap-
proach is based on the description by Futuyma [48] in
which the homologous genes from different species evolve
at much higher rates than others, and also, when a single
gene pool changes, it can evolve into new species.
BpHyase was visualized in a separate branch, which indi-
cates an independent evolution of this toxin when com-
pared to hyaluronidases and hyaluronidases-like proteins
from Bitis, Echis and Cerastis genders [49]. The most in-
teresting observation is that hyaluronidases-like proteins
are, until now, described only for Bothrops pauloensis,
Echis carinatus and Bitis arietans venoms, which inhabit
different continents. All these observations suggest that
hyaluronidases-like proteins may share a common ances-
tor, thus presenting a broad distribution among venomous
snakes.Conclusions
Herein we have reported the first hyaluronidase-like
cDNA sequence from a Brazilian snake venom. The in
silico analysis of its deduced amino acid sequence opens
new perspectives concerning its biological functions,
suggesting a regulatory role that needs to be investi-
gated. Moreover, this work may guide further studies
comprising their isolation and/or recombinant produc-
tion, as well as their detailed structural and functional
characterization.
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